Bill
Bill > HB4347
MI HB4347
MI HB4347Health: pharmaceuticals; reports on certain costs and other information associated with prescription drugs; require manufacturers of prescription drugs to file with the department. Creates new act. TIE BAR WITH: HB 4353'21
summary
Introduced
02/24/2021
02/24/2021
In Committee
03/25/2021
03/25/2021
Crossed Over
03/24/2021
03/24/2021
Passed
Dead
12/31/2022
12/31/2022
Introduced Session
101st Legislature
Bill Summary
A bill to require drug manufacturers to report certain information to the department of insurance and financial services; to provide for the powers and duties of certain state officers and entities; to allow for the promulgation of rules; and to prescribe civil sanctions.
AI Summary
This bill, the "Drug Manufacturer Data Reporting Act," requires drug manufacturers to report certain information to the Michigan Department of Insurance and Financial Services, including details on drug price increases, research and development costs, and the introduction of new high-cost prescription drugs. The bill grants the department the authority to promulgate rules and impose civil fines for non-compliance. It also exempts the reported information from public disclosure under the Freedom of Information Act. The bill's implementation is contingent on the enactment of a related bill, House Bill No. 4353.
Committee Categories
Health and Social Services
Sponsors (14)
Sue Allor (R)*,
Joe Bellino (R)*,
Bob Bezotte (R)*,
Ken Borton (R)*,
Tommy Brann (R)*,
Kelly Breen (D)*,
Julie Calley (R)*,
Diana Farrington (R)*,
Annette Glenn (R)*,
Brad Paquette (R)*,
Mary Whiteford (R)*,
Angela Witwer (D)*,
Doug Wozniak (R)*,
Jeff Yaroch (R)*,
Last Action
Referred To Committee On Health Policy And Human Services (on 03/25/2021)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Loading...